REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Exergy21 Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Soap, Cleaning Compound, and Toilet Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Exergy21 Co., Ltd. Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Exergy21 Co., Ltd.. is engaged in manufacturing, supply and distribution of pharmaceutical raw materials, healthcare products and cosmetics. The company is based in Seoul, South Korea. Exergy21 Co., Ltd.. was incorporated in 1987.

Headquarters
99 Digital-Ro 9 Gil, Geumcheon-Gu
Seoul; Seoul; Postal Code: 153-777

Contact Details: Purchase the Exergy21 Co., Ltd. report to view the information.

Website: http://www.pharmswell.com

Basic Information
Total Employees:
Purchase the Exergy21 Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Exergy21 Co., Ltd. report to view the information.
Registered Capital:
Purchase the Exergy21 Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Exergy21 Co., Ltd. report to view the information.
Incorporation Date:
April 16, 1987
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
2.2%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Exergy21 Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
239.48%▲
Total operating revenue
56.19%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-6063.63%▼
Total assets
25.94%▲
Total equity
10.41%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-175.18%▼
Return on Equity (ROE)
-39.07%▼
Debt to Equity Ratio
3.31%▲
Quick Ratio
0.34%▲
Cash Ratio
-0.47%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Sunbio, Inc.
 
Tego Science, Inc.
Anterogen Co.,Ltd.
 
Pangen Biotech Inc.
St Cube Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo